Nationwide Fund Advisors’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-29,221
| Closed | -$44K | – | 3220 |
|
|
2017
Q2 | $44K | Buy |
29,221
+8,270
| +39% | +$12.5K | ﹤0.01% | 3067 |
|
|
2017
Q1 | $54K | Sell |
20,951
-25,877
| -55% | -$66.7K | ﹤0.01% | 2972 |
|
|
2016
Q4 | $119K | Buy |
46,828
+21,400
| +84% | +$54.4K | ﹤0.01% | 2815 |
|
|
2016
Q3 | $79K | Sell |
25,428
-7,989
| -24% | -$24.8K | ﹤0.01% | 2969 |
|
|
2016
Q2 | $107K | Buy |
33,417
+7,989
| +31% | +$25.6K | ﹤0.01% | 2884 |
|
|
2016
Q1 | $79K | Hold |
25,428
| – | – | ﹤0.01% | 2888 |
|
|
2015
Q4 | $102K | Sell |
25,428
-31,000
| -55% | -$124K | ﹤0.01% | 2841 |
|
|
2015
Q3 | $258K | Hold |
56,428
| – | – | ﹤0.01% | 2442 |
|
|
2015
Q2 | $293K | Sell |
56,428
-1,884
| -3% | -$9.78K | ﹤0.01% | 2519 |
|
|
2015
Q1 | $365K | Buy |
58,312
+13,387
| +30% | +$83.8K | ﹤0.01% | 2405 |
|
|
2014
Q4 | $283K | Hold |
44,925
| – | – | ﹤0.01% | 2481 |
|
|
2014
Q3 | $273K | Buy |
44,925
+389
| +0.9% | +$2.36K | ﹤0.01% | 2542 |
|
|
2014
Q2 | $293K | Buy |
44,536
+12,094
| +37% | +$79.6K | ﹤0.01% | 2542 |
|
|
2014
Q1 | $772K | Sell |
32,442
-261
| -0.8% | -$6.21K | ﹤0.01% | 1860 |
|
|
2013
Q4 | $350K | Sell |
32,703
-575
| -2% | -$6.15K | ﹤0.01% | 2408 |
|
|
2013
Q3 | $444K | Buy |
33,278
+10,555
| +46% | +$141K | ﹤0.01% | 2283 |
|
|
2013
Q2 | $298K | Buy |
+22,723
| New | +$298K | ﹤0.01% | 2302 |
|